Transport of the synthetic opioid peptide DADLE ([d-Ala2,d-Leu5]-Enkephalin) in neuronal cells

Journal of Pharmaceutical Sciences

Volumn 101, Issue 1, 2012, Pages 154-163

  Ananth, Sudha ^a   Thakkar, Santoshanand V ^a   Gnana prakasam, Jaya P ^a   Martin, Pamela M ^a   Ganapathy, Preethi S ^a   Smith, Sylvia B ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Active transport; Cell penetrating peptides; Drug transport; Neuronal cells; Opioid peptides; Peptide delivery; Peptide transporters; Retinal ganglion cell

Indexed keywords

ARGININE; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; FLUORESCEIN ISOTHIOCYANATE; GLYCINE; ISOLEUCINE; LEUCINE; LYSINE; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; PHENYLALANINE; PROLINE; SODIUM COUPLED OLIGOPEPTIDE TRANSPORTER 1; SODIUM COUPLED OLIGOPEPTIDE TRANSPORTER 2; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RETINA NERVE CELL;

EID: 82255191684     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22733     Document Type: Article

References (27)

1. Su TP. 2000. Delta opioid peptide [d-Ala(2), d-Leu(5)]enkephalin promotes cell survival. J Biomed Sci 7:195-199.
2. Borlongan CV, Wang Y, Su TP. 2004. Delta opioid peptide (d-Ala 2, d-Leu 5)enkephalin: Linking hibernation and neuroprotection. Front Biosci 9:3392-3398.
3. Peart JN, Gross ER, Gross GJ. 2005. Opioid-induced preconditioning: Recent advances and future perspectives. Vascul Pharmacol 42:211-218.
4. Baldelli B, Vecchio L, Biggiogera M, Vittoria E, Muzzonigro G, Gazzanelli G, Malatesta M. 2004. Ultrastructural and immunocytochemical analyses of opioid treatment effects on PC3 prostatic cancer cells. Microsc Res Tech 64:243-249.
5. Baldelli B, Vecchio L, Bottone MG, Muzzonigro G, Biggiogera M, Malatesta M. 2006. The effect of the enkephalin DADLE on transcription does not depend on opioid receptors. Histochem Cell Biol 126:189-197.
6. Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A. 2003. Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [d-Ala2, d-Leu5]-enkephalin. J Pharm Pharmacol 55:1013-1020.
7. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. 2000. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294:73-79.
8. Ismair MG, Stieger B, Cattori V, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick GA. 2001. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology 121:1185-1190.
9. Ganapathy V, Miyauchi S. 2005. Transport systems for opioid peptides in mammalian tissues. AAPS J 7:E852-E856.
10. --coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat. Biochem J 375:17-22.
11. Chothe P, Thakkar SV, Gnana-Prakasam JP, Ananth S, Hinton DR, Kannan R, Smith SB, Martin PM, Ganapathy V. 2010. Identification of a novel sodium-coupled oligopeptide transporter (SOPT2) in mouse and human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 51:413-420.
12. Miyauchi S, Gopal E, Thakkar SV, Ichikawa S, Prasad PD, Ganapathy V. 2007. Differential modulation of sodium- and chloride-dependent opioid peptide transport system by small non-opioid peptides and free amino acids. J Pharmacol Exp Ther 321:257-264.
13. +-coupled peptide transporter PEPT2. Drug Metab Pharmacokinet 23:254-262.
14. Chothe PP, Singh N, Ganapathy V. 2011. Evidence for two different broad-specific oligopeptide transporters in the intestinal cell line Caco-2 and the colonic cell line CCD841. Am J Physiol Cell Physiol 300:C1260-C1269.
15. Ananth S, Karunakaran S, Martin PM, Nagineni CN, Hooks JJ, Smith SB, Prasad PD, Ganapathy V. 2009. Functional identification of a novel transport system for endogenous and synthetic opioid peptides in the rabbit conjunctival cell line CJVE. Pharm Res 26:1226-1235.
16. Hussain S, Potter DE, Crosson CE. 2009. Opioid receptor activation: Retina protected from ischemic injury. Invest Ophthalmol Vis Sci 50:3853-3859.
17. Peng PH, Huang HS, Lee YJ, Chen YS, Ma MC. 2009. Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas. J Neurochem 108:741-754.
18. Dun Y, Thangaraju M, Prasad PD, Ganapathy V, Smith SB. 2007. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand. Invest Ophthalmol Vis Sci 48:4785-4794.
19. -) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res 324:189-202.
20. Dun Y, Duplantier J, Roon P, Martin PM, Ganapathy V, Smith SB. 2008. Serine racemase expression and d-serine content are developmentally regulated in neuronal ganglion cells of the retina. J Neurochem 104:970-978.
21. Chothe PP, Gnana-Prakasam JP, Ananth S, Martin PM, Kannan R, Hinton DR, Smith SB, Ganapathy V. 2011. Transport of hepcidin, an iron-regulatory peptide hormone, into retinal pigment epithelial cells via oligopeptide transporters and its relevance to iron homeostasis. Biochem Biophys Res Commun 405:244-249.
22. Van Bergen NJ, Wood JP, Chidlow G, Trounce IA, Casson RJ, Ju WK, Weinreb RN, Crowston JG. 2009. Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci 50:4267-4272.
23. Zagon IS, Verderame MF, McLaughlin PJ. 2002. The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 38:351-376.
24. Henriques ST, Melo MN, Castanho ARB. 2006. Cell-penetrating peptides and antimicrobial peptides: How different are they? Biochem J 399:1-7.
25. Fonseca SB, Pereira MP, Kelley SO. 2009. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 61:953-964.
26. Deshayes S, Morris MC, Divita G, Heitz F. 2005. Cell-penetrating peptides: Tools for intracellular delivery of therapeutics. Cell Mol Life Sci 62:1839-1849.
27. Dietz GP. 2010. Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research. Curr Pharm Biotechnol 11:167-174.